FDA Adverse Event Injury Summary report: N

MOTO PARTIAL KNEE ANATOMICAL FEMORAL COMPONENT CEMENTED S5 - LATER

MDR report key: 11017686 · Received December 16, 2020

Report

Report Number
3005180920-2020-00939
Event Type
Injury
Date Received
December 16, 2020
Date of Event
November 25, 2020
Report Date
December 16, 2020
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
HSX
UDI-DI
07630040720694
PMA / PMN Number
K183029
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

BATCH REVIEW PERFORMED ON 04 DECEMBER 2020: LOT 1906794: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 13-NOV-2019. EXPIRATION DATE: 2024-11-02. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. ADDITIONAL DEVICE INVOLVED: BATCH REVIEWS PERFORMED ON 04 DECEMBER 2020: MOTO PARTIAL KNEE 02.18.IF6.08.LLRL TIBIAL INSERT FIX S6 - LATERAL - 8MM (K183029) LOT 1906756: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 31-OCT-2019. EXPIRATION DATE: 2024-10-12. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. MOTO PARTIAL KNEE 02.18.TF6.RL TIBIAL TRAY FIX CEMENTED S6 RL (K183029) LOT 1906787: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 11-DEC-2019. EXPIRATION DATE: 2024-11-30. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT.

Description of Event or Problem · 1

THE PATIENT CAME IN, ONE MONTH AFTER PRIMARY SURGERY, REPORTING PAIN DUE TO OSTEOPOROSIS. THE SURGEON REVISED THE FEMORAL COMPONENT, TIBIAL TRAY, AND INSERT. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1481430 MOTO PARTIAL KNEE ANATOMICAL FEMORAL COMPONENT CEMENTED S5 - LATER KNEE FEMORAL COMPONENT HSX MEDACTA INTERNATIONAL SA 1906794 07630040720694

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention